HCWB - Latest News
HCW Biologics Inc. (HCWB), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.2M. Beta to the broader market is 2.36.
The article list below shows the most recent HCWB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent HCWB Headlines
HCW Biologics' TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
globenewswire.com - Aug 25, 2026
Human studies show that the TGF-β trap and IL-15 fusion used alone promotes expansion of progenitor CD8 + T cells and NK cells Company has incorporate
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
globenewswire.com - Aug 14, 2026
MIRAMAR, Fla. , Aug.
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
globenewswire.com - Jul 29, 2026
MIRAMAR, Fla. , July 29, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc.
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
globenewswire.com - Jul 23, 2026
Company requested Type B pre-IND meeting with U. S.
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
globenewswire.com - Jun 30, 2026
MIRAMAR, Fla. , June 30, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc.
How News Affects HCWB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track HCWB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked HCWB news questions
- What is the latest HCWB news headline?
- The most recent HCWB headline (Aug 25, 2026) is "HCW Biologics' TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the HCWB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What HCWB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual HCWB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.